Literature DB >> 26242372

Poorly Differentiated Carcinoma Component in Submucosal Layer Should be Considered as an Additional Criterion for Curative Endoscopic Resection of Early Gastric Cancer.

Da Hyun Jung1,2, Yoon Sung Bae3, Sun Och Yoon3, Yong Chan Lee1, Hoguen Kim3, Sung Hoon Noh4, Hyojin Park1,2, Seung Ho Choi2,4, Jie-Hyun Kim5,6, Hyunki Kim7.   

Abstract

BACKGROUND: Some studies have reported lymph node metastasis (LNM) in early gastric cancer (EGC) cases meeting the expanded criteria for endoscopic resection. Therefore, we investigated whether a minor poorly differentiated carcinoma (PDC) component in the submucosal (SM) layer affects LNM in differentiated EGC.
METHODS: We performed surgery in 1096 patients with differentiated SM gastric cancer and compared the clinicopathologic features of node-positive (n = 194) and node-negative (n = 902) differentiated SM cancer, with special reference to the portion of PDC component in the SM layer.
RESULTS: When we categorized patients by the proportion of PDC component in the SM layer, we found 840 patients had <5 % and 256 patients had ≥5 % PDC components in the SM layer. The ≥5 % group was significantly associated with younger age, female sex, moderate differentiation, deep SM invasion, lymphovascular invasion (LVI), perineural invasion, and LNM. In multivariate analysis, middle third location, moderate differentiation, SM2 invasion, size >2 cm, LVI, and PDC components in the SM layer were independent risk factors for LNM. When we limited the depth of invasion to SM1, the incidence of LNM was significantly higher in the ≥5 % group. On multivariate analysis, tumor size >2 cm, moderate differentiation, LVI positivity, and ≥5 % PDC components in the SM1 layer were independent risk factors for LNM in SM1 cancer.
CONCLUSIONS: The PDC component in the SM layer of differentiated EGC was an independent risk factor of LNM, which might constitute a supplementary criterion in the expanded indications for endoscopic resection in differentiated EGC.

Entities:  

Mesh:

Year:  2015        PMID: 26242372     DOI: 10.1245/s10434-015-4794-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  8 in total

1.  A Risk-Scoring Model for Predicting Lymph Node Metastasis in Early Gastric Cancer Patients: a Retrospective Study and External Validation.

Authors:  Lihu Gu; Manman Chen; Parikshit Asutosh Khadaroo; Xueqiang Ma; Liya Kong; Xinlong Li; Hepan Zhu; Xin Zhong; Junhai Pan; XianFa Wang
Journal:  J Gastrointest Surg       Date:  2018-05-29       Impact factor: 3.452

2.  Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm.

Authors:  Cheol Keun Park; Ji Soo Park; Hyo Song Kim; Sun Young Rha; Woo Jin Hyung; Jae-Ho Cheong; Sung Hoon Noh; Sang Kil Lee; Yong Chan Lee; Yong-Min Huh; Hyunki Kim
Journal:  Oncotarget       Date:  2016-11-01

Review 3.  Management of Superficial Esophageal Squamous Cell Carcinoma and Early Gastric Cancer following Non-Curative Endoscopic Resection.

Authors:  Waku Hatta; Tomoyuki Koike; Kaname Uno; Naoki Asano; Atsushi Masamune
Journal:  Cancers (Basel)       Date:  2022-08-02       Impact factor: 6.575

4.  The function of Notch1 intracellular domain in the differentiation of gastric cancer.

Authors:  Sunkuan Hu; Qiuxiang Chen; Tiesu Lin; Wandong Hong; Wenzhi Wu; Ming Wu; Xiaojing Du; Rong Jin
Journal:  Oncol Lett       Date:  2018-02-26       Impact factor: 2.967

5.  Favorable Long-Term Outcomes of Endoscopic Submucosal Dissection for Differentiated-Type-Predominant Early Gastric Cancer with Histological Heterogeneity.

Authors:  Tae-Se Kim; Hyeong Chan Shin; Byung-Hoon Min; Kyoung-Mee Kim; Yang Won Min; Hyuk Lee; Jun Haeng Lee; Poong-Lyul Rhee; Jae J Kim
Journal:  J Clin Med       Date:  2020-04-09       Impact factor: 4.241

6.  Japanese gastric cancer treatment guidelines 2018 (5th edition).

Authors: 
Journal:  Gastric Cancer       Date:  2020-02-14       Impact factor: 7.370

7.  Clinicopathologic Features of Submucosal Papillary Gastric Cancer Differ from Those of Other Differentiated-Type Histologies.

Authors:  Seung Yong Shin; Jie-Hyun Kim; Myeong-Cherl Kook; Do Youn Park; Keun Won Ryu; Il Ju Choi; Sung Hoon Noh; Hyunki Kim; Yong Chan Lee
Journal:  Gut Liver       Date:  2021-01-15       Impact factor: 4.519

8.  Comparison of Survival and Patterns of Recurrence in Gastric Neuroendocrine Carcinoma, Mixed Adenoneuroendocrine Carcinoma, and Adenocarcinoma.

Authors:  Jianxian Lin; Yajun Zhao; Yanbing Zhou; Yantao Tian; Qingliang He; Junpeng Lin; Hankun Hao; Bingbing Zou; Lixin Jiang; Gang Zhao; Wei Lin; Yanchang Xu; Zhi Li; Fangqin Xue; Shuliang Li; Weihua Fu; Yongxiang Li; Zekuan Xu; Yong Li; Jinping Chen; Xiaojun Zhou; Zhenggang Zhu; Lisheng Cai; En Li; Honglang Li; Chaohui Zheng; Ping Li; Changming Huang; Jianwei Xie
Journal:  JAMA Netw Open       Date:  2021-07-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.